SG10201602144PA - Methods and devices for assessing risk to a putative offspring of developing a condition - Google Patents

Methods and devices for assessing risk to a putative offspring of developing a condition

Info

Publication number
SG10201602144PA
SG10201602144PA SG10201602144PA SG10201602144PA SG10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA SG 10201602144P A SG10201602144P A SG 10201602144PA
Authority
SG
Singapore
Prior art keywords
developing
condition
methods
devices
assessing risk
Prior art date
Application number
SG10201602144PA
Other languages
English (en)
Inventor
Piraye Yurttas Beim
Original Assignee
Celmatix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celmatix Inc filed Critical Celmatix Inc
Publication of SG10201602144PA publication Critical patent/SG10201602144PA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201602144PA 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition SG10201602144PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161542324P 2011-10-03 2011-10-03

Publications (1)

Publication Number Publication Date
SG10201602144PA true SG10201602144PA (en) 2016-04-28

Family

ID=48044379

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201602144PA SG10201602144PA (en) 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition
SG11201401222WA SG11201401222WA (en) 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201401222WA SG11201401222WA (en) 2011-10-03 2012-10-02 Methods and devices for assessing risk to a putative offspring of developing a condition

Country Status (9)

Country Link
US (1) US20130109583A1 (fr)
EP (2) EP3323897A1 (fr)
JP (1) JP2015527870A (fr)
KR (1) KR20140072160A (fr)
AU (2) AU2012318734A1 (fr)
CA (1) CA2850930A1 (fr)
IL (1) IL231861B (fr)
SG (2) SG10201602144PA (fr)
WO (1) WO2013052505A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150038778A1 (en) * 2012-03-14 2015-02-05 Cewntree Hospitalier Universitaire Pontchaillou Itih5 as a diagnostic marker of uterine development and functional defects
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
ES2701069T3 (es) 2012-12-21 2019-02-20 Epizyme Inc Inhibidores de PRMT5 y sus usos
CN103525921A (zh) * 2013-09-27 2014-01-22 西北农林科技大学 一种利用3基因聚合效应选育山羊产羔性状的方法
SG11201700303UA (en) 2014-07-17 2017-02-27 Celmatix Inc Methods and systems for assessing infertility and related pathologies
WO2016057852A1 (fr) * 2014-10-08 2016-04-14 The Broad Institute, Inc. Marqueurs de cancers hématologiques
US20180291450A1 (en) * 2015-03-27 2018-10-11 The Johns Hopkins University Method of identifying risk for autism
AU2016357720A1 (en) 2015-11-18 2018-07-05 Genzyme Corporation Biomarker of polycystic kidney disease and uses thereof
KR101906312B1 (ko) * 2016-02-05 2018-10-10 사회복지법인 삼성생명공익재단 추정 자손의 유전질환 발병 위험성을 예측하는 방법 및 시스템
US20170351806A1 (en) * 2016-06-03 2017-12-07 Celmatix Inc. Method for assessing fertility based on male and female genetic and phenotypic data
CN105886655A (zh) * 2016-06-24 2016-08-24 天津市畜牧兽医研究所 一种检测猪nlrp6的核苷酸序列及应用
KR20190121781A (ko) * 2017-02-01 2019-10-28 뉴사우스 이노베이션즈 피티와이 리미티드 생식 세포-분비된 성장 인자들
CA3057613A1 (fr) * 2017-03-15 2018-09-20 Juneau Biosciences, L.L.C. Procedes d'utilisation de marqueurs genetiques associes a l'endometriose
CN108315410B (zh) * 2018-04-28 2019-07-12 南京医科大学 一组评估早期流产风险的dna甲基化标志物、引物及其应用
EP3935581A4 (fr) 2019-03-04 2022-11-30 Iocurrents, Inc. Compression et communication de données à l'aide d'un apprentissage automatique
US20220186312A1 (en) * 2020-12-11 2022-06-16 Guzip Biomarkers Corporation Predictive method for assessing the success of embryo implantation
CN113203780B (zh) * 2021-05-13 2022-05-31 桂林电子科技大学 一种非诊断目的无标记适配体传感器检测gpc3的方法
WO2023159225A2 (fr) * 2022-02-18 2023-08-24 Precidiag, Inc. Signatures microbiennes de trouble du spectre autistique
CN114592048A (zh) * 2022-03-10 2022-06-07 天津大学温州安全(应急)研究院 预测复发性流产人群孕期凝血功能异常的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6100029A (en) 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6028189A (en) 1997-03-20 2000-02-22 University Of Washington Solvent for oligonucleotide synthesis and methods of use
US6566101B1 (en) 1997-06-16 2003-05-20 Anthony P. Shuber Primer extension methods for detecting nucleic acids
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US7013221B1 (en) 1999-07-16 2006-03-14 Rosetta Inpharmatics Llc Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays
CA2415775A1 (fr) 2000-07-18 2002-01-24 Correlogic Systems, Inc. Procede de distinction d'etats biologiques sur la base de types caches de donnees biologiques
WO2002072892A1 (fr) 2001-03-12 2002-09-19 California Institute Of Technology Procedes et appareil d'analyse de sequences de polynucleotide par extension de base asynchrone
US6890763B2 (en) 2001-04-30 2005-05-10 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
WO2003095978A2 (fr) 2002-05-09 2003-11-20 Surromed, Inc. Procedes d'alignement temporel de donnees obtenues par chromatographie liquide ou par spectrometrie de masse
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US20060195266A1 (en) 2005-02-25 2006-08-31 Yeatman Timothy J Methods for predicting cancer outcome and gene signatures for use therein
US20060234274A1 (en) * 2005-03-29 2006-10-19 Auckland Uniservices Limited Methods of diagnosis
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7282337B1 (en) 2006-04-14 2007-10-16 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
EP2653861B1 (fr) 2006-12-14 2014-08-13 Life Technologies Corporation Procédé pour le séquençage d'un acide nucléique en utilisant des matrices de FET à grande échelle
US8722333B2 (en) * 2007-03-06 2014-05-13 Rutgers, The State University Of New Jersey GSTP1 as teratogenic allele for autism and assays and methods based thereon
US20090156412A1 (en) 2007-12-17 2009-06-18 Helicos Biosciences Corporation Surface-capture of target nucleic acids
US8394587B2 (en) * 2008-04-14 2013-03-12 Medical Diagnostic Laboratories, Llc Single nucleotide polymorphisms and use of same predicting male-specific prenatal loss
US20100035252A1 (en) 2008-08-08 2010-02-11 Ion Torrent Systems Incorporated Methods for sequencing individual nucleic acids under tension
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US8546128B2 (en) 2008-10-22 2013-10-01 Life Technologies Corporation Fluidics system for sequential delivery of reagents
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US8574835B2 (en) 2009-05-29 2013-11-05 Life Technologies Corporation Scaffolded nucleic acid polymer particles and methods of making and using
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
EP2443259A4 (fr) * 2009-06-16 2012-10-10 Univ Columbia Biomarqueurs associés à l'autisme et utilisations de ces derniers
JP2013503646A (ja) * 2009-09-08 2013-02-04 ラボラトリー コーポレイション オブ アメリカ ホールディングス 自閉症スペクトラム障害を診断するための組成物および方法
CA2774618C (fr) * 2009-09-23 2020-10-27 Celmatix, Inc. Procedes et dispositifs pour evaluer la sterilite et/ou la qualite des ovules

Also Published As

Publication number Publication date
WO2013052505A3 (fr) 2014-05-22
EP2764122A2 (fr) 2014-08-13
CA2850930A1 (fr) 2013-04-11
EP2764122A4 (fr) 2015-06-17
EP2764122B1 (fr) 2017-12-06
IL231861B (en) 2018-12-31
AU2018205068A1 (en) 2018-07-26
US20130109583A1 (en) 2013-05-02
SG11201401222WA (en) 2014-09-26
WO2013052505A2 (fr) 2013-04-11
KR20140072160A (ko) 2014-06-12
IL231861A0 (en) 2014-05-28
AU2012318734A1 (en) 2014-04-17
JP2015527870A (ja) 2015-09-24
EP3323897A1 (fr) 2018-05-23

Similar Documents

Publication Publication Date Title
IL231861B (en) Methods and standards for assessing the risk attributed to the offspring of developing a medical condition
GB2508124B (en) Methods and systems to determine a context of a device
EP2788909A4 (fr) Agencements médicaux et procédé pour la prévision d'une valeur associée à un état médical
GB201406056D0 (en) Assessing social risk due to exposure from linked contacts
EP2741678A4 (fr) Evaluation pupillométrique d'une compréhension de langue
EP2693373A4 (fr) Dispositif de mesure du nombre de personnes
EP2770823A4 (fr) Animaux transgéniques et leurs procédés d'utilisation
IL228066A0 (en) Methods for diagnosing aneuploidy in human embryos
SG2014013387A (en) Devices for testing a battery and methods for testing a battery
RS58967B1 (sr) Metod evaluacije rizika za pml
GB2489592B (en) Developing device
EP2721404A4 (fr) Diagnostic et pronostic de lésion rénale et d'insuffisance rénale
ZA201207064B (en) Device and method to determine shape of streamer
GB2487662B (en) Developing device
GB201102171D0 (en) Inspection of holes
EP2670436A4 (fr) Anticorps anti-foxc1 et leurs procédés d'utilisation
EP2677934A4 (fr) Procédés de surveillance d'exposition à un événement et dispositifs correspondants
NO20111156A1 (no) Anordning for hopp- og vannaktiviteter
PL394036A1 (pl) Sposób oceny stanu technicznego transformatorów
SI2702430T1 (sl) Postopek za ocenjevanje zanesljivosti para pes-človek in komplet za izvajanje omenjenega postopka
GB201200649D0 (en) Guitar floating bridge device
GB201108774D0 (en) A device for measurement of tension in a rope
TH128207B (th) วิธีการและอุปกรณ์สำหรับกู้ชีพนักดำน้ำที่หายใจอึดอัด
PL394802A1 (pl) Sposób automatycznego naliczania rabatów transakcji oraz uklady urzadzen do tego sposobu